Related Experiment Video
Updated: Jun 30, 2026

Comet Assay as an Indirect Measure of Systemic Oxidative Stress
Published on: May 22, 2015
A Comparative Study on Genotoxic and Oxidative DNA Damage in Oral Epithelial Cells of COVID-19 Suspected Patients
Yogitha Poojari1, Senthil Murugan1, P K Sankaran2
1Anatomy, All India Institute Of Medical Sciences, Mangalagiri, IND.
Abstract:
Introduction The SARS-CoV-2 virus causes COVID-19 by chiefly infecting the nasal and oral mucosal cavities, where its spike proteins bind to angiotensin-converting enzyme II (ACE2) receptors on epithelial cells. This study aimed to assess SARS-CoV-2-related genotoxicity in buccal mucosal cells through micronuclei counts and 8-Oxo-2'-deoxyguanosine (8-OHdG) expression. Methods This cross-sectional study was conducted in 86 COVID-19 suspected patients aged 18-45 years attending an outpatient screening area for reverse transcription polymerase chain reaction (RT-PCR) SARS-CoV-2 testing between December 2023 and February 2024. Salivary swabs were obtained and smeared on glass slides for each patient. These slides were stained to study and compare cellular toxicity by Papanicolaou (Pap) staining and oxidative DNA damage expression by immunohistochemistry. The categorical and continuous variables were assessed using the independent t-test and ANOVA. A p-value of less than 0.05 was considered statistically significant. Results The number of micronucleated cells, total micronuclei, neutrophil, lymphocyte and inflammatory cell count in COVID-19 RT-PCR positive patients were 11.32 ± 7.00, 17.32± 12.53, 1.93 ± 1.17, 3.98 ± 2.55 and 5.90 ± 3.15 respectively which is higher than COVID-19 RT-PCR negative individuals 6.09± 3.83, 9.04± 5.82, 0.18± 0.49, 2.13± 0.84 and 2.31±1.01 respectively. Moreover, buccal cells showed increased oxidative DNA damage with intense staining for 8-OHdG in COVID-19-positive patients. The epithelial-to-inflammatory cell ratio was very low in COVID-19-positive buccal smear patients. Conclusion This study concludes that SARS-CoV-2 has a genotoxic effect by increasing the micronuclei count and has oxidative DNA damage by increasing the 8-OHdG expression in the exfoliated buccal cells.
Insights
COVID-19 infection by SARS-CoV-2 causes genotoxicity in buccal cells, increasing micronuclei and oxidative DNA damage (8-OHdG). This highlights the virus
Area of Science:
- Molecular Biology
- Genetics
- Virology
- Cell Biology
Background:
- SARS-CoV-2 primarily infects the nasal and oral mucosa, utilizing spike proteins to bind ACE2 receptors on epithelial cells.
- Understanding the genotoxic effects of SARS-CoV-2 infection on host cells is crucial for assessing long-term health implications.
Purpose of the Study:
- To evaluate the genotoxicity of SARS-CoV-2 in buccal mucosal cells.
- To assess micronuclei counts and 8-Oxo-2'-deoxyguanosine (8-OHdG) expression as indicators of DNA damage in COVID-19 patients.
Main Methods:
- A cross-sectional study involving 86 patients aged 18-45 years undergoing RT-PCR testing for SARS-CoV-2.
- Salivary swabs were collected, stained using Papanicolaou (Pap) staining for cellular toxicity, and assessed for 8-OHdG expression via immunohistochemistry.
- Statistical analysis included independent t-tests and ANOVA, with a p-value < 0.05 considered significant.
Main Results:
- COVID-19 RT-PCR positive patients exhibited significantly higher counts of micronucleated cells, total micronuclei, neutrophils, lymphocytes, and inflammatory cells compared to negative individuals.
- Buccal cells from COVID-19 positive patients showed increased oxidative DNA damage, evidenced by intense 8-OHdG staining.
- A lower epithelial-to-inflammatory cell ratio was observed in COVID-19 positive patients' buccal smears.
Conclusions:
- SARS-CoV-2 infection exerts a genotoxic effect on exfoliated buccal cells, indicated by elevated micronuclei counts.
- The virus also induces oxidative DNA damage in buccal cells, as demonstrated by increased 8-OHdG expression.
- These findings suggest significant cellular and DNA damage in the oral mucosa following SARS-CoV-2 infection.

